-
1.
Steiner AZ, Jukic AMZ. Impact of female age and nulligravidity on fecundity in an older reproductive age cohort. Fertil Steril 2016; 105:1584–1588.e1. doi: 10.1016/j.fertnstert.2016.02.028
-
2.
Hansen KR, et al. A new model of reproductive aging: The decline in ovarian nongrowing follicle number from birth to menopause. Hum Reprod 2008; 23:699–708. doi: 10.1093/humrep/dem408
-
3.
Colvin OM. An overview of cyclophosphamide development and clinical applications. Curr Pharm Des 1999; 5:555–560. PMID: 10469891
-
4.
Practice Committee of the American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: A committee opinion. Fertil Steril 2019; 112:1022–1033. doi: 10.1016/j.fertnstert.2019.09.013
-
5.
Practice Committee of the American Society for Reproductive Medicine; Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: A guideline. Fertil Steril 2013; 99:37–43. doi: 10.1016/j.fertnstert.2012.09.028
-
6.
von Wolff M, et al.; FertiPROTEKT Study Group. Timing of ovarian stimulation in patients prior to gonadotoxic therapy: An analysis of 684 stimulations. Eur J Obstet Gynecol Reprod Biol 2016; 199:146–149. doi: 10.1016/j.ejogrb.2016.02.006
Chronic Kidney Disease, Female Infertility, and Fertility Preservation
Search for other papers by Lauren Weissmann in
Current site
Google Scholar
PubMed
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory